{"id":56439,"date":"2023-05-02T15:06:18","date_gmt":"2023-05-02T13:06:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/"},"modified":"2023-05-02T15:06:18","modified_gmt":"2023-05-02T13:06:18","slug":"hildred-capital-management-completes-strategic-investment-in-aleracare","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/","title":{"rendered":"Hildred Capital Management Completes Strategic Investment in AleraCare"},"content":{"rendered":"
\n

\nCapital will be used by AleraCare to double clinical capacity over the next 24-months in an effort to provide even greater support to patients and providers<\/i><\/b><\/p>\n

NEW YORK–(BUSINESS WIRE)–Hildred Capital Management, (\u201cHildred\u201d or the \u201cFirm\u201d) a healthcare-focused private equity firm that specializes in partnering with middle-market companies to help scale their businesses and create value, today announced that it has completed a strategic investment in AleraCare<\/a>, (the \u201cCompany\u201d) a leading provider of infusion and specialty pharmacy services across the country.<\/p>\n

\nFounded in 2019, AleraCare\u2019s core lines of business include ambulatory infusion centers, home infusion therapy, specialty pharmacy and compounding pharmacy. Administered by best-in-class clinicians at convenient, accessible, patient-first locations, AleraCare is focused on maintaining trusted-partner status with physicians, payors and pharmaceutical manufacturer partners. The Company has rapidly expanded to over 35 ambulatory infusion centers across the country and has achieved success to date by being a provider-of-choice for infusion services to high-need and medically complex populations.<\/p>\n

\n\u201cHildred brings a wealth of experience to AleraCare given the team\u2019s deep operational expertise and proven record of helping healthcare service providers create long-term value,\u201d said Russ Corvese, Chief Executive Officer of AleraCare. \u201cWe are thrilled to partner with the team at Hildred and greatly appreciate their support as we continue our mission of satisfying patients\u2019 and physicians\u2019 expectations and being recognized as a trusted partner and preferred destination for innovative, accessible and advanced patient-focused site of care services.\u201d<\/p>\n

\n\u201cWe seek to back exceptional management teams in structurally attractive healthcare sectors that have sizeable market potential, excellent growth prospects, attractive innovation opportunities and manageable pricing trends and competition,\u201d said Andrew Goldman, Co-Founder and Managing Partner of Hildred. \u201cAleraCare meets this criteria and we believe the Company is poised for even greater success.\u201d<\/p>\n

\nStephen Hallenbeck, Managing Director at Hildred, added, \u201cRuss and the entire AleraCare team have done a remarkable job of building what we believe is a fantastic business that possesses significant growth potential. We are looking forward to partnering with them to help further scale the business and provide strategic support, as appropriate.\u201d<\/p>\n

\nAleraCare will use the capital provided by Hildred to further enhance its platform for all existing and future patients as it continues to grow its physical footprint, and advance physician-coordinated care standards through comprehensive and convenient infusion service offerings.<\/p>\n

\nHolland & Knight served as legal counsel for Hildred Capital. K&L Gates and Kudman Law served as legal counsel for AleraCare and Cantor Fitzgerald served as the Company\u2019s exclusive financial advisor.<\/p>\n

\nAbout Hildred Capital Management<\/b><\/p>\n

\nHildred Capital Management is a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies. The Firm specializes in partnering with management teams to help them scale their platforms, generate earnings growth, promote strategic and operational improvements, generate business development, and drive multiple expansion. For more information, please visit <\/b>www.hildredcapital.com<\/a> and follow the Firm on LinkedIn<\/a>.<\/p>\n

\nAbout AleraCare<\/b><\/p>\n

\nAleraCare is a leading provider of infusion treatments and pharmacy services for high-need and medically complex populations. The Company\u2019s core lines of business include AleraCare advanced home infusion, AleraCare advanced specialty pharmacy, and AleraCare advanced compounding pharmacy. AleraCare provides care to patients in over 35 locations across eight states throughout the United States, including Arizona, California, Colorado, Idaho, New Mexico, Oregon, Utah and Washington. For more information, please visit www.aleracare.com<\/a> and follow the Company on LinkedIn<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia<\/b>
Mike Geller
\n
Prosek Partners
\n
646-818-9018
\n
mgeller@prosek.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Capital will be used by AleraCare to double clinical capacity over the next 24-months in an effort to provide even greater support to patients and providers NEW YORK–(BUSINESS WIRE)–Hildred Capital Management, (\u201cHildred\u201d or the \u201cFirm\u201d) a healthcare-focused private equity firm that specializes in partnering with middle-market companies to help scale their businesses and create value, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56439","6":"format-standard","7":"category-industry"},"yoast_head":"\nHildred Capital Management Completes Strategic Investment in AleraCare - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hildred Capital Management Completes Strategic Investment in AleraCare - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Capital will be used by AleraCare to double clinical capacity over the next 24-months in an effort to provide even greater support to patients and providers NEW YORK–(BUSINESS WIRE)–Hildred Capital Management, (\u201cHildred\u201d or the \u201cFirm\u201d) a healthcare-focused private equity firm that specializes in partnering with middle-market companies to help scale their businesses and create value, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-02T13:06:18+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hildred-capital-management-completes-strategic-investment-in-aleracare\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hildred-capital-management-completes-strategic-investment-in-aleracare\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Hildred Capital Management Completes Strategic Investment in AleraCare\",\"datePublished\":\"2023-05-02T13:06:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hildred-capital-management-completes-strategic-investment-in-aleracare\\\/\"},\"wordCount\":579,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hildred-capital-management-completes-strategic-investment-in-aleracare\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hildred-capital-management-completes-strategic-investment-in-aleracare\\\/\",\"name\":\"Hildred Capital Management Completes Strategic Investment in AleraCare - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-05-02T13:06:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hildred-capital-management-completes-strategic-investment-in-aleracare\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hildred-capital-management-completes-strategic-investment-in-aleracare\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hildred-capital-management-completes-strategic-investment-in-aleracare\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hildred Capital Management Completes Strategic Investment in AleraCare\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hildred Capital Management Completes Strategic Investment in AleraCare - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/","og_locale":"en_US","og_type":"article","og_title":"Hildred Capital Management Completes Strategic Investment in AleraCare - Pharma Trend","og_description":"Capital will be used by AleraCare to double clinical capacity over the next 24-months in an effort to provide even greater support to patients and providers NEW YORK–(BUSINESS WIRE)–Hildred Capital Management, (\u201cHildred\u201d or the \u201cFirm\u201d) a healthcare-focused private equity firm that specializes in partnering with middle-market companies to help scale their businesses and create value, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/","og_site_name":"Pharma Trend","article_published_time":"2023-05-02T13:06:18+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Hildred Capital Management Completes Strategic Investment in AleraCare","datePublished":"2023-05-02T13:06:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/"},"wordCount":579,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/","url":"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/","name":"Hildred Capital Management Completes Strategic Investment in AleraCare - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-05-02T13:06:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/hildred-capital-management-completes-strategic-investment-in-aleracare\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hildred Capital Management Completes Strategic Investment in AleraCare"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56439","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56439"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56439\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56439"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56439"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56439"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}